FindTrial
Sign In

Effects of low thoracic erector spinal plane block for patients undergoing abdominal hysterectomy under general anaesthesia

A study to assess the efficacy of low thoracic erector spinae plane block(ESPB) for postoperative analgesia in patients undergoing abdominal hysterectomy under general anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032896
Enrollment
70
Registered
2021-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Low thoracic erector spinae plane block with general anaesthesia: Erector spinae plane Block using ROPIVACAINE 0.25% 15 ml + 15 ml bilaterally at T10 level ) is given once below erect

Sponsors

JLN medical college Ajmer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 25 and 60 years Body weight 30 to 80 kg Patients belonging to ASA (American Society of Anaesthesiologists) class 1 and 2 Patients undergoing abdominal hysterectomy of duration 1 to 2 hours in theatre with haemoglobin atleast 9 gm/dl Patient free from any associated acute or chronic systemic illness

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study Uncooperative patients Patient with chronic pain or on long-term analgesics Any known hypersensitivity or contraindication to bupivacaine Local pathology at the site of injection or disability limiting the performance of block,(deformity of spine) Patients receiving beta blockers or cardiac drugs. History of convulsion, allergy to the drug used, bleeding disorder, severe neurological deficit, thyroid disorder Patient with history of respiratory, cardiac, hepatic or renal disease (necessitating classification in ASA Class III or above) Patients having a history of significant neurological, psychiatric, or neuromuscular disorders Pregnant, lactating mothers

Design outcomes

Primary

MeasureTime frame
Comparison of Number and frequency of postoperative analgesia required in both the groups for First 36 hours Postoperatively To assess the effective analgesia by visual analog scale (VAS) scoreTimepoint: Around 1 year—

Secondary

MeasureTime frame
To assess and compare the hemodynamic changes . To assess and compare the proportion of patients having adverse effects and any Ã?  other complications. Ã?  Ã?  Ã?  Ã?  Ã?  Ã? Ã?  To assess Sensory and motor block if any in the ESPB group.Timepoint: Around 1 year—

Countries

India

Contacts

Public ContactDr Kavita Jain

JLN medical college Ajmer

drkavitajain15@gmail.com9414006151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026